Work

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

Year: 2003

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Pontus K E Börjesson, Ernst J Postema, Jan C Roos, David R Colnot, Henri A M Marres, Mathijs H van Schie, Gerd Stehle, Remco de Bree, Gordon B Snow, Wim J G Oyen, Guus A M S van Dongen

Institution: Amsterdam UMC Location Vrije Universiteit Amsterdam

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1863821115

FWCI: 3.358

Cites: 32

Cited by: 113

Related to: 10